Drug Gene Delivery System Market

Drug and Gene Delivery Systems Market (Delivery System - Drug Delivery Systems, Gene Delivery Systems; Route of Administration - Oral, Injectable, Inhalation, Transdermal, Ocular, Nasal, Topical; Application - Infectious Diseases, Oncology, Ophthalmology, Urology, Diabetes, CNS) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017-2025

  • Rep Id : TMRGL26135
  • Published On : Mar 2018
  • No. of Pages : 334
  • Category : Pharmaceutical

Section 1 Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

Section 2 Assumptions and Research Methodology

Section 3 Executive Summary

Section 4 Market Overview
4.1. Product Definitions
4.2. Overview
4.3. Market Dynamics
      4.3.1. Drivers
      4.3.2. Restraints
      4.3.3 Opportunities
4.4. Global Drug and Gene Delivery System Market Forecast
4.5. Porter's Five Forces Analysis
4.6. Global Drug and Gene Delivery System Market Outlook
4.7. Technological Advancements in Drug and Gene Delivery Products
4.8. Regulatory Scenario
4.9. Key Mergers & Acquisitions
4.10. Drug and Gene Therapy Pipeline

Section 5 Global Drug and Gene Delivery Systems Market Analysis, by Delivery System
5.1. Key Findings / Developments
5.2. Introduction: Drug Delivery Systems
5.3. Introduction: Gene Delivery Systems
5.4. Introduction & Definitions
5.5. Global Drug and Gene Delivery Systems Market Value Share Analysis, by Drug Delivery System
5.6. Global Drug and Gene Delivery Systems Market Value Share Analysis, by Gene Delivery System
5.7. Global Drug and Gene Delivery Systems Market Forecast, by Drug Delivery System
      5.7.1.      Intrauterine Implants
      5.7.2. Prodrug Implants
      5.7.3. Polymeric Drug Delivery
      5.7.4. Targeted Drug Delivery
5.8. Global Drug and Gene Delivery Systems Market Forecast, by Gene Delivery System
      5.8.1. Viral Gene Delivery
      5.8.2. Non-viral Gene Delivery
      5.8.3. Combined Hybrid Systems
5.9. Global Drug and Gene Delivery Systems Market Forecast, by Gene Delivery System: Viral Gene Delivery
      5.9.1. Adenovirus Vector
      5.9.2. Lentivirus Vector
      5.9.3. Retrovirus Vector
      5.9.4. Adeno-associated Virus Vector
      5.9.5. Sendai Virus Vector
      5.9.6. Herpes Simplex Virus Vector
      5.9.7. Others
5.10. Global Drug and Gene Delivery Systems Market Forecast, by Gene Delivery System: Non-viral Gene Delivery
      5.10.1. Natural Organic Compounds
      5.10.2. Physical Methods
      5.10.3. Chemical Methods
5.11. Global Drug and Gene Delivery Systems Market Analysis, by Drug Delivery System
5.12. Global Drug and Gene Delivery Systems Market Analysis, by Gene Delivery System
5.13. Global Drug and Gene Delivery Systems Market Analysis, by Gene Delivery System: Viral Gene Delivery
5.14. Global Drug and Gene Delivery Systems Market Attractiveness Analysis, by Drug Delivery System
5.15. Global Drug and Gene Delivery Systems Market Attractiveness Analysis, by Gene Delivery System

Section 06 Global Drug and Gene Delivery System Market Analysis, by Application
6.1. Key Findings / Developments
6.2. Introduction & Definitions
6.3. Introduction: Drug Delivery Systems
6.4. Introduction: Gene Delivery Systems
6.5. Global Drug Delivery System Market Value Share Analysis, by Application
6.6. Global Gene Delivery System Market Value Share Analysis, by Application
6.7. Global Drug Delivery System Market Forecast, by Application
      6.8.1. Infectious Diseases
      6.8.2. Oncology
      6.8.3. Ophthalmology
      6.8.4. Urology
      6.8.5. Diabetes
      6.8.6. CNS
      6.8.7. Others
6.9. Global Gene Delivery System Market Forecast, by Application
      6.9.1. Infectious Diseases
      6.9.2. Oncology
      6.9.3. Ophthalmology
      6.9.4. Urology
      6.9.5. Diabetes
      6.9.6. CNS
      6.9.7. Others
6.10. Global Drug Delivery System Market Attractiveness, by Application
6.11. Global Gene Delivery System Market Attractiveness, by Application

Section 07 Global Drug and Gene Delivery Systems Market Analysis, by Route of Administration
7.1. Key Findings
7.2. Introduction & Definitions
7.3. Introduction: Drug Delivery Systems
7.4. Introduction: Gene Delivery Systems
7.5. Global Drug Delivery Systems Market, by Route of Administration
7.6. Global Gene Delivery Systems Market Value Share Analysis, by Route of Administration
7.7. Global Drug Delivery Systems Market Forecast, by Route of Administration
      7.7.1. Oral
      7.7.2. Injectable
      7.7.3. Inhalation
      7.7.4. Transdermal
      7.7.5. Ocular
      7.7.6. Nasal
      7.7.7. Topical
7.8. Global Gene Delivery Systems Market Forecast, by Route of Administration
      7.8.1. Oral
      7.8.2. Injectable
      7.8.3. Inhalation
      7.8.4. Transdermal
      7.8.5. Ocular
      7.8.6. Nasal
      7.8.7. Topical
7.9. Global Drug and Gene Delivery Systems Market Attractiveness Analysis, by Drug Delivery: Route of Administration
7.10. Global Drug and Gene Delivery Systems Market Attractiveness Analysis, by Gene Delivery: Route of Administration

Section 08 Global Drug and Gene Delivery Systems Market Analysis, by Region
8.1. Global Drug and Gene Delivery System Market Overview
8.2. Introduction
8.3. Global Drug and Gene Delivery System Market Value Share Analysis, by Region
8.4. Global Drug and Gene Delivery System Market Forecast, by Region
      8.4.1. North America
      8.4.2. Europe
      8.4.3. Asia Pacific
      8.4.4. Middle East & Africa
      8.4.5. Latin America
8.5. Global Drug and Gene Delivery System Market Attractiveness Analysis, by Region

Section 09 North America Drug and Gene Delivery System Market Analysis
9.1. Key Findings
9.2. North America Drug and Gene Delivery System Market Overview
9.3. North America Drug and Gene Delivery System Market Overview, by Country
9.4. North America Drug and Gene Delivery System Market Value Share Analysis, by Country
9.5. North America Drug Delivery System Market Forecast, by Country
      9.5.1. U.S.
      9.5.2. Canada
9.6. North America Gene Delivery System Market Forecast, by Country
      9.6.1. U.S.
      9.6.2. Canada
9.7. North America Drug and Gene Delivery System Market Value Share Analysis, by Delivery System
9.8. North America Drug and Gene Delivery System Market Forecast, by Drug Delivery System
      9.8.1. Intrauterine Implants
      9.8.2. Prodrug Implants
      9.8.3. Polymeric Drug Delivery
      9.8.4. Targeted Drug Delivery
9.9. North America Drug and Gene Delivery System Market Forecast, by Gene Delivery System
      9.9.1. Viral Gene Delivery
      9.9.2. Non-viral Gene Delivery
      9.9.3. Combined Hybrid System
9.10. North America Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery
9.11. North America Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery
9.12. North America Gene Delivery System Market Forecast, by Viral Gene Delivery
      9.12.1. Adenovirus Vector
      9.12.2. Lentivirus Vector
      9.12.3. Retrovirus Vector
      9.12.4. Adeno-associated Virus Vector
      9.12.5. Sendai Virus Vector
      9.12.6. Herpes Simplex Virus Vector
      9.12.7. Others
9.13. North America Gene Delivery System Market Forecast, by Non-viral Gene Delivery
      9.13.1. Natural Organic Compounds
      9.13.2. Physical Methods
      9.13.3. Chemical Methods
9.14. North America Drug and Gene Delivery System Market Value Share Analysis, by Application
9.15. North America Drug Delivery System Market Forecast, by Application
      9.15.1. Infectious Diseases
      9.15.2. Oncology
      9.15.3. Ophthalmology
      9.15.4. Urology
      9.15.5. Diabetes
      9.15.6. CNS
      9.15.7. Others
9.16. North America Gene Delivery System Market Forecast, by Application
      9.16.1. Infectious Diseases
      9.16.2. Oncology
      9.16.3. Ophthalmology
      9.16.4. Urology
      9.16.5. Diabetes
      9.16.6. CNS
      9.16.7. Others
9.17. North America Drug and Gene Delivery System Market Value Share Analysis, by Route of Administration
9.18. North America Drug Delivery System Market Forecast, by Route of Administration
      9.18.1. Oral
      9.18.2. Injectable
      9.18.3. Inhalation
      9.18.4. Transdermal
      9.18.5. Ocular
      9.18.6. Nasal
      9.18.7. Topical
9.19. North America Gene Delivery System Market Forecast, by Route of Administration
9.20. North America Drug and Gene Delivery System Market Attractiveness Analysis

Section 10 Europe Drug and Gene Delivery System Market Analysis
10.1. Key Findings
10.2. Europe Drug and Gene Delivery System Market Overview
10.3. Europe Drug and Gene Delivery System Market Overview, by Country/Sub-region
10.4. Europe Drug and Gene Delivery System Market Value Share Analysis, by Country/Sub-region
10.5. Europe Drug Delivery System Market Forecast, by Country/Sub-region
      10.5.1. Germany
      10.5.2. U.K.
      10.5.3. France
      10.5.4. Italy
      10.5.5. Spain
      10.5.6. Rest of Europe
10.6. Europe Gene Delivery System Market Forecast, by Country/Sub-region
      10.6.1. Germany
      10.6.2. U.K.
      10.6.3. France
      10.6.4. Italy
      10.6.5. Spain
      10.6.6. Rest of Europe
10.7. Europe Drug and Gene Delivery System Market Value Share Analysis, by Delivery System
10.8. Europe Drug and Gene Delivery System Market Forecast, by Drug Delivery System
      10.8.1. Intrauterine Implants
      10.8.2. Prodrug Implants
      10.8.3. Polymeric Drug Delivery
      10.8.4. Targeted Drug Delivery
10.9. Europe Drug and Gene Delivery System Market Forecast, by Gene Delivery System
      10.9.1. Viral Gene Delivery
      10.9.2. Non-viral Gene Delivery
      10.9.3. Combined Hybrid System
10.10. Europe Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery
10.11. Europe Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery
10.12. Europe Gene Delivery System Market Forecast, by Viral Gene Delivery
      10.12.1. Adenovirus Vector
      10.12.2. Lentivirus Vector
      10.12.3. Retrovirus Vector
      10.12.4. Adeno-associated Virus Vector
      10.12.5. Sendai Virus Vector
      10.12.6. Herpes Simplex Virus Vector
      10.12.7. Others
10.13. Europe Gene Delivery System Market Forecast, by Non-viral Gene Delivery
      10.13.1. Natural Organic Compounds
      10.13.2. Physical Methods
      10.13.3. Chemical Methods
10.14. Europe Drug and Gene Delivery System Market Value Share Analysis, by Application
10.15. Europe Drug Delivery System Market Forecast, by Application
      10.15.1. Infectious Diseases
      10.15.2. Oncology
      10.15.3. Ophthalmology
      10.15.4. Urology
      10.15.5. Diabetes
      10.15.6. CNS
      10.15.7. Others
10.16. Europe Gene Delivery System Market Forecast, by Application
      10.16.1. Infectious Diseases
      10.16.2. Oncology
      10.16.3. Ophthalmology
      10.16.4. Urology
      10.16.5. Diabetes
      10.16.6. CNS
      10.16.7. Others
10.17. Europe Drug and Gene Delivery System Market Value Share Analysis, by Route of Administration
10.18. Europe Drug Delivery System Market Forecast, by Route of Administration
      10.18.1. Oral
      10.18.2. Injectable
      10.18.3. Inhalation
      10.18.4. Transdermal
      10.18.5. Ocular
      10.18.6. Nasal
      10.18.7. Topical
10.19. Europe Gene Delivery System Market Forecast, by Route of Administration
10.20. Europe Drug and Gene Delivery System Market Attractiveness Analysis

Section 11 Asia Pacific Drug and Gene Delivery System Market Analysis
11.1. Key Findings
11.2. Asia Pacific Drug and Gene Delivery System Market Overview
11.3. Asia Pacific Drug and Gene Delivery System Market Overview, by Country/Sub-region
11.4. Asia Pacific Drug and Gene Delivery System Market Value Share Analysis, by Country/Sub-region
11.5. Asia Pacific Drug Delivery System Market Forecast, by Country/Sub-region
      11.5.1. Japan
      11.5.2. China
      11.5.3. India
      11.5.4. Australia & New Zealand
      11.5.5. Rest of Asia Pacific
11.6. Asia Pacific Drug Delivery System Market Forecast, by Country/Sub-region
      11.6.1. Japan
      11.6.2. China
      11.6.2. India
      11.6.4. Australia & New Zealand
      11.6.5. Rest of Asia Pacific
11.7. Asia Pacific Drug and Gene Delivery System Market Value Share Analysis, by Delivery System
11.8. Asia Pacific Drug and Gene Delivery System Market Forecast, by Drug Delivery System
      11.8.1. Intrauterine Implants
      11.8.2. Prodrug Implants
      11.8.3. Polymeric Drug Delivery
      11.8.4. Targeted Drug Delivery
11.9. Asia Pacific Drug and Gene Delivery System Market Forecast, by Gene Delivery System
      11.9.1. Viral Gene Delivery
      11.9.2. Non-viral Gene Delivery
      11.9.3. Combined Hybrid System
11.10. Asia Pacific Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery
11.11. Asia Pacific Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery
11.12. Asia Pacific Gene Delivery System Market Forecast, by Viral Gene Delivery
      11.12.1. Adenovirus Vector
      11.12.2. Lentivirus Vector
      11.12.3. Retrovirus Vector
      11.12.4. Adeno-associated Virus Vector
      11.12.5. Sendai Virus Vector
      11.12.6. Herpes Simplex Virus Vector
      11.12.7. Others
11.13. Asia Pacific Gene Delivery System Market Forecast, by Non-viral Gene Delivery
      11.13.1. Natural Organic Compounds
      11.13.2. Physical Methods
      11.13.3. Chemical Methods
11.14. Asia Pacific Drug and Gene Delivery System Market Value Share Analysis, by Application
11.15. Asia Pacific Drug Delivery System Market Forecast, by Application
      11.15.1. Infectious Diseases
      11.15.2. Oncology
      11.15.3. Ophthalmology
      11.15.4. Urology
      11.15.5. Diabetes
      11.15.6. CNS
      11.15.7. Others
11.16. Asia Pacific Gene Delivery System Market Forecast, by Application
      11.16.1. Infectious Diseases
      11.16.2. Oncology
      11.16.3. Ophthalmology
      11.16.4. Urology
      11.16.5. Diabetes
      11.16.6. CNS
      11.16.7. Others
11.17. Asia Pacific Drug and Gene Delivery System Market Value Share Analysis, by Route of Administration
11.18. Asia Pacific Drug Delivery System Market Forecast, by Route of Administration
      11.18.1. Oral
      11.18.2. Injectable
      11.18.3. Inhalation
      11.18.4. Transdermal
      11.18.5. Ocular
      11.18.6. Nasal
      11.18.7. Topical
11.19. Asia Pacific Gene Delivery System Market Forecast, by Route of Administration
11.20. Asia Pacific Drug and Gene Delivery System Market Attractiveness Analysis

Section 12 Latin America Drug and Gene Delivery System Market Analysis
12.1. Key Findings
12.2. Latin America Drug and Gene Delivery System Market Overview
12.3. Latin America Drug and Gene Delivery System Market Overview, by Country/Sub-region
12.4. Latin America Drug and Gene Delivery System Market Value Share Analysis, by Country/Sub-region
12.5. Latin America Drug Delivery System Market Forecast, by Country/Sub-region
      12.5.1. Brazil
      12.5.2. Mexico
      12.5.3. Rest of Latin America
12.6. Latin America Gene Delivery System Market Forecast, by Country/Sub-region
      12.6.1. Brazil
      12.6.2. Mexico
      12.6.3. Rest of Latin America
12.7. Latin America Drug and Gene Delivery System Market Value Share Analysis, by Delivery System
12.8. Latin America Drug and Gene Delivery System Market Forecast, by Drug Delivery System
      12.8.1. Intrauterine Implants
      12.8.2. Prodrug Implants
      12.8.3. Polymeric Drug Delivery
      12.8.4. Targeted Drug Delivery
12.9. Latin America Drug and Gene Delivery System Market Forecast, by Gene Delivery System
      12.9.1. Viral Gene Delivery
      12.9.2. Non-viral Gene Delivery
      12.9.3. Combined Hybrid System
12.10. Latin America Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery
12.11. Latin America Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery
12.12. Latin America Gene Delivery System Market Forecast, by Viral Gene Delivery
      12.12.1. Adenovirus Vector
      12.12.2. Lentivirus Vector
      12.12.3. Retrovirus Vector
      12.12.4. Adeno-associated Virus Vector
      12.12.5. Sendai Virus Vector
      12.12.6. Herpes Simplex Virus Vector
      12.12.7. Others
12.13. Latin America Gene Delivery System Market Forecast, by Non-viral Gene Delivery
      12.13.1. Natural Organic Compounds
      12.13.2. Physical Methods
      12.13.3. Chemical Methods
12.14. Latin America Drug and Gene Delivery System Market Value Share Analysis, by Application
12.15. Latin America Drug Delivery System Market Forecast, by Application
      12.15.1. Infectious Diseases
      12.15.2. Oncology
      12.15.3. Ophthalmology
      12.15.4. Urology
      12.15.5. Diabetes
      12.15.6. CNS
      12.15.7. Others
12.16. Latin America Gene Delivery System Market Forecast, by Application
      12.16.1. Infectious Diseases
      12.16.2. Oncology
      12.16.3. Ophthalmology
      12.16.4. Urology
      12.16.5. Diabetes
      12.16.6. CNS
      12.16.7. Others
12.17. Latin America Drug and Gene Delivery System Market Value Share Analysis, by Route of Administration
12.18. Latin America Drug Delivery System Market Forecast, by Route of Administration
      12.18.1. Oral
      12.18.2. Injectable
      12.18.3. Inhalation
      12.18.4. Transdermal
      12.18.5. Ocular
      12.18.6. Nasal
      12.18.7. Topical
12.19. Latin America Gene Delivery System Market Forecast, by Route of Administration
12.20. Latin America Drug and Gene Delivery System Market Attractiveness Analysis

Section 13 Middle East & Africa Drug and Gene Delivery System Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Drug and Gene Delivery System Market Overview
13.3. Middle East & Africa Drug and Gene Delivery System Market Overview, by Country/Sub-region
13.4. Middle East & Africa Drug and Gene Delivery System Market Value Share Analysis, by Country/Sub-region
13.5. Middle East & Africa Drug Delivery System Market Forecast, by Country/Sub-region
      13.5.1. GCC
      13.5.2. South Africa
      13.5.3. Israel
      13.5.4. Rest of MEA
13.6. Middle East & Africa Drug Delivery System Market Forecast, by Country/Sub-region
      13.6.1. GCC
      13.6.2. South Africa
      13.6.3. Israel
      13.6.4. Rest of MEA
13.7. Middle East & Africa Drug and Gene Delivery System Market Value Share Analysis, by Delivery System
13.8. Middle East & Africa Drug and Gene Delivery System Market Forecast, by Drug Delivery System
      13.8.1. Intrauterine Implants
      13.8.2. Prodrug Implants
      13.8.3. Polymeric Drug Delivery
      13.8.4. Targeted Drug Delivery
13.9. Middle East & Africa Drug and Gene Delivery System Market Forecast, by Gene Delivery System
      13.9.1. Viral Gene Delivery
      13.9.2. Non-viral Gene Delivery
      13.9.3. Combined Hybrid System
13.10. Latin America Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery
13.11. Middle East & Africa Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery
13.12. Middle East & Africa Gene Delivery System Market Forecast, by Viral Gene Delivery
      13.12.1. Adenovirus Vector
      13.12.2. Lentivirus Vector
      13.12.3. Retrovirus Vector
      13.12.4. Adeno-associated Virus Vector
      13.12.5. Sendai Virus Vector
      13.12.6. Herpes Simplex Virus Vector
      13.12.7. Others
13.13. Middle East & Africa Gene Delivery System Market Forecast, by Non-viral Gene Delivery
      13.13.1. Natural Organic Compounds
      13.13.2. Physical Methods
      13.13.3. Chemical Methods
13.14. Middle East & Africa Drug and Gene Delivery System Market Value Share Analysis, by Application
13.15. Middle East & Africa Drug Delivery System Market Forecast, by Application
      13.15.1. Infectious Diseases
      13.15.2. Oncology
      13.15.3. Ophthalmology
      13.15.4. Urology
      13.15.5. Diabetes
      13.15.6. CNS
      13.15.7. Others
13.16. Middle East & Africa Gene Delivery System Market Forecast, by Application
      13.16.1. Infectious Diseases
      13.16.2. Oncology
      13.16.3. Ophthalmology
      13.16.4. Urology
      13.16.5. Diabetes
      13.16.6. CNS
      13.16.7. Others
13.17. Middle East & Africa Drug and Gene Delivery System Market Value Share Analysis, by Route of Administration
13.18. Middle East & Africa Drug Delivery System Market Forecast, by Route of Administration
      13.18.1. Oral
      13.18.2. Injectable
      13.18.3. Inhalation
      13.18.4. Transdermal
      13.18.5. Ocular
      13.18.6. Nasal
      13.18.7. Topical
13.19. Middle East & Africa Gene Delivery System Market Forecast, by Route of Administration
13.20. Middle East & Africa Drug and Gene Delivery System Market Attractiveness Analysis

Section 14 Competition Landscape
14.1. Competition Matrix

Section 15 Company Profiles
15.1. Novartis AG
      15.1.1. Company Description
      15.1.2. Financial Overview
      15.1.3. Strategy & Recent Developments
      15.1.4. SWOT Analysis
15.2. Amgen Inc.
      15.2.1. Company Description
      15.2.2. Financial Overview
      15.2.3. Strategy & Recent Developments
      15.2.4. SWOT Analysis
15.3. Oxford BioMedica plc.
      15.3.1. Company Description
      15.3.2. Financial Overview
      15.3.3. Strategy & Recent Developments
      15.3.4. SWOT Analysis
15.4. SIBIONO
      15.4.1. Company Description
      15.4.2. Financial Overview
      15.4.3. Strategy & Recent Developments
      15.4.4. SWOT Analysis
15.5. Shanghai Sunway Biotech Co., Ltd.
      15.5.1. Company Description
      15.5.2. Financial Overview
      15.5.3. Strategy & Recent Developments
      15.5.4. SWOT Analysis
15.6. F. Hoffmann-La Roche Ltd.
      15.6.1. Company Description
      15.6.2. Financial Overview
      15.6.3. Strategy & Recent Developments
      15.6.4. SWOT Analysis
15.7. Pfizer, Inc.
      15.7.1. Company Description
      15.7.2. Financial Overview
      15.7.3. Strategy & Recent Developments
      15.7.4. SWOT Analysis
15.8. Bayer AG
      15.8.1. Company Description
      15.8.2. Financial Overview
      15.8.3. Strategy & Recent Developments
      15.8.4. SWOT Analysis
15.9. Johnson & Johnson Services, Inc.
      15.9.1. Company Description
      15.9.2. Financial Overview
      15.9.3. Strategy & Recent Developments
      15.9.4. SWOT Analysis
15.10. Becton, Dickinson and Company
      15.10.1. Company Description
      15.10.2. Financial Overview
      15.10.3. Strategy & Recent Developments
      15.10.4. SWOT Analysis
15.11. AstraZeneca plc.
      15.11.1. Company Description
      15.11.2. Financial Overview
      15.11.3. Strategy & Recent Developments
      15.11.4. SWOT Analysis
15.12. Baxter International, Inc.
      15.12.1. Company Description
      15.12.2. Financial Overview
      15.12.3. Strategy & Recent Developments
      15.12.4. SWOT Analysis
15.13. Human Stem Cells Institute
      15.13.1. Company Description
      15.13.2. Financial Overview
      15.13.3. Strategy & Recent Developments
      15.13.4. SWOT Analysis
15.14. Boston Scientific Corporation
      15.14.1. Company Description
      15.14.2. Financial Overview
      15.14.3. Strategy & Recent Developments
      15.14.4. SWOT Analysis
15.15. Epeius Biotechnologies Corporation
      15.15.1. Company Description
      15.15.2. Financial Overview
      15.15.3. Strategy & Recent Developments
      15.15.4. SWOT Analysis

List of Tables

Table 01: Regulatory Scenario in Different Countries
Table 02: Gene Therapy Pipeline Molecules
Table 03: Drug Therapy Pipeline Products
Table 04: Global Drug and Gene Delivery Systems Market Size (US$ Bn) Forecast, by Drug Delivery System, 2015–2025
Table 05: Global Drug and Gene Delivery Systems Market Size (US$ Mn) Forecast, by Gene Delivery System, 2015–2025
Table 06: Global Drug and Gene Delivery Systems Market Size (US$ Mn) Forecast, by Gene Delivery System: Viral Gene Delivery, 2015–2025
Table 07: Global Drug and Gene Delivery Systems Market Size (US$ Mn) Forecast, by Gene Delivery System: Non-viral Gene Delivery, 2015–2025
Table 08: Global Drug Delivery System Market Value (US$ Bn) Forecast, by Application, 2015–2025
Table 09: Global Gene Delivery System Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 10: Global Drug and Gene Delivery Systems Market Value (US$ Bn) Forecast, by Drug Delivery: Route of Administration, 2015–2025
Table 11: Global Drug and Gene Delivery Systems Market Value (US$ Mn) Forecast, by Gene Delivery: Route of Administration, 2015–2025
Table 12: Global Drug and Gene Delivery System Market Size (US$ Bn) Forecast, by Region, 2015–2025
Table 13: North America Drug Delivery System Market Size (US$ Bn) Forecast, by Country, 2015–2025
Table 14: North America Gene Delivery System Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 15: North America Drug and Gene Delivery System Market Size (US$ Bn) Forecast, by Drug Delivery System, 2015–2025
Table 16: North America Drug and Gene Delivery System Market Size (US$ Mn) Forecast, by Gene Delivery System, 2015–2025
Table 17: North America Gene Delivery System Market Size (US$ Mn) Forecast, by Viral Gene Delivery, 2015–2025
Table 18: North America Gene Delivery System Market Size (US$ Mn) Forecast, by Non-viral Gene Delivery, 2015–2025
Table 19: North America Drug Delivery System Market Size (US$ Bn) Forecast, by Application, 2015–2025
Table 20: North America Gene Delivery System Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 21: North America Drug Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 22: North America Gene Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 23: Europe Drug Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
Table 24: Europe Gene Delivery System Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 25: Europe Drug and Gene Delivery System Market Size (US$ Bn) Forecast, by Drug Delivery System, 2015–2025
Table 26: Europe Drug and Gene Delivery System Market Size (US$ Mn) Forecast, by Gene Delivery System, 2015–2025
Table 27: Europe Gene Delivery System Market Size (US$ Mn) Forecast, by Viral Gene Delivery, 2015–2025
Table 28: Europe Gene Delivery System Market Size (US$ Mn) Forecast, by Non-viral Gene Delivery, 2015–2025
Table 29: Europe Drug Delivery System Market Size (US$ Bn) Forecast, by Application, 2015–2025
Table 30: Europe Gene Delivery System Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 31: Europe Drug Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 32: Europe Gene Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 33: Asia Pacific Drug Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
Table 34: Asia Pacific Gene Delivery System Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 35: Asia Pacific Drug and Gene Delivery System Market Size (US$ Bn) Forecast, by Drug Delivery System, 2015–2025
Table 36: Asia Pacific Drug and Gene Delivery System Market Size (US$ Mn) Forecast, by Gene Delivery System, 2015–2025
Table 37: Asia Pacific Gene Delivery System Market Size (US$ Mn) Forecast, by Viral Gene Delivery, 2015–2025
Table 38: Asia Pacific Gene Delivery System Market Size (US$ Mn) Forecast, by Non-viral Gene Delivery, 2015–2025
Table 39: Asia Pacific Drug Delivery System Market Size (US$ Bn) Forecast, by Application, 2015–2025
Table 40: Asia Pacific Gene Delivery System Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 41: Asia Pacific Drug Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 42: Asia Pacific Gene Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 43: Latin America Drug Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
Table 44: Latin America Gene Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
Table 45: Latin America Drug and Gene Delivery System Market Size (US$ Bn) Forecast, by Drug Delivery System, 2015–2025
Table 46: Latin America Drug and Gene Delivery System Market Size (US$ Mn) Forecast, by Gene Delivery System, 2015–2025
Table 47: Latin America Gene Delivery System Market Size (US$ Mn) Forecast, by Viral Gene Delivery, 2015–2025
Table 48: Latin America Gene Delivery System Market Size (US$ Mn) Forecast, by Non-viral Gene Delivery, 2015–2025
Table 49: Latin America Drug Delivery System Market Size (US$ Bn) Forecast, by Application, 2015–2025
Table 50: Latin America Gene Delivery System Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 51: Latin America Drug Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 52: Latin America Gene Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 53: Middle East & Africa Drug Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
Table 54: Middle East & Africa Gene Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
Table 55: Middle East & Africa Drug and Gene Delivery System Market Size (US$ Bn) Forecast, by Drug Delivery System, 2015–2025
Table 56: Middle East & Africa Drug and Gene Delivery System Market Size (US$ Mn) Forecast, by Gene Delivery System, 2015–2025
Table 57: Middle East & Africa Gene Delivery System Market Size (US$ Mn) Forecast, by Viral Gene Delivery, 2015–2025, 2015–2025
Table 58: Middle East & Africa Gene Delivery System Market Size (US$ Mn) Forecast, by Non-viral Gene Delivery, 2015–2025
Table 59: Middle East & Africa Drug Delivery System Market Size (US$ Bn) Forecast, by Application, 2015–2025
Table 60: Middle East & Africa Gene Delivery System Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 61: Middle East & Africa Drug Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 62: Middle East & Africa Gene Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025

 

List of Figures

Figure 01: Global Drug and Gene Delivery System Market Snapshot
Figure 02: Global Drug and Gene Delivery System Market Size (US$ Bn), by Route of Administration, 2016
Figure 03: Global Drug and Gene Delivery System Market Size (US$ Mn), by Region, 2016 and 2025
Figure 04: Global Drug and Gene Delivery System Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
Figure 05: Global Drug and Gene Delivery System Market Value Share, by Type of Gene Delivery System (2016)
Figure 06: Global Drug Delivery System Market Value Share, by Type of Drug Delivery System (2016)
Figure 07: Global Drug and Gene Delivery System Market Value Share, by Application (2016)
Figure 08: Global Drug and Gene Delivery Systems Market Value Share, by Drug Delivery System, 2016 and 2025
Figure 09: Global Drug and Gene Delivery Systems Market Value Share, by Gene Delivery System, 2016 and 2025
Figure 10: Global Drug and Gene Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Drug Delivery System: Intrauterine Implants, 2015–2025
Figure 11: Global Drug and Gene Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Drug Delivery System: Prodrug Implants, 2015–2025
Figure 12: Global Drug and Gene Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Drug Delivery System: Polymeric Drug Delivery, 2015–2025
Figure 13: Global Drug and Gene Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Drug Delivery System: Targeted Drug Delivery, 2015–2025
Figure 14: Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Gene Delivery System: Viral Gene Delivery, 2015–2025
Figure 15: Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Gene Delivery System: Non-viral Gene Delivery, 2015–2025
Figure 16: Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Gene Delivery System: Combined Hybrid Systems, 2015–2025
Figure 17: Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viral Gene Delivery: Adenovirus Vector, 2015–2025
Figure 18: Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viral Gene Delivery: Lentivirus Vector, 2015–2025
Figure 19: Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viral Gene Delivery: Retrovirus Vector, 2015–2025
Figure 20: Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viral Gene Delivery: Adeno-associated Virus Vector, 2015–2025
Figure 21: Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viral Gene Delivery: Sendai Virus Vector, 2015–2025
Figure 22: Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viral Gene Delivery: Herpes Simplex Virus Vector, 2015–2025
Figure 23: Global Drug and Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viral Gene Delivery: Others, 2015–2025
Figure 24: Global Drug and Gene Delivery Systems Market Attractiveness, by Drug Delivery System, 2017–2025
Figure 25: Global Drug and Gene Delivery Systems Market Attractiveness, by Gene Delivery System, 2017–2025
Figure 26: Global Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 27: Global Gene Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 28: Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Infectious Diseases, 2015–2025
Figure 29: Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Oncology, 2015–2025
Figure 30: Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Ophthalmology, 2015–2025
Figure 31: Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Urology, 2015–2025
Figure 32: Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Diabetes, 2015–2025
Figure 33: Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by CNS, 2015–2025
Figure 34: Global Drug Delivery System Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 35: Global Gene Delivery System Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Infectious Diseases, 2015–2025
Figure 36: Global Gene Delivery System Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oncology, 2015–2025
Figure 37: Global Gene Delivery System Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ophthalmology, 2015–2025
Figure 38: Global Gene Delivery System Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Urology, 2015–2025
Figure 39: Global Gene Delivery System Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diabetes, 2015–2025
Figure 40: Global Gene Delivery System Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CNS, 2015–2025
Figure 41: Global Gene Delivery System Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 42: Global Drug Delivery System Market Attractiveness, by Application, 2017–2025
Figure 43: Global Gene Delivery System Market Attractiveness, by Application, 2017–2025
Figure 44: Global Drug and Gene Delivery Systems Market Value Share, by Drug Delivery: Route of Administration, 2016 and 2025
Figure 45: Global Gene Delivery Systems Market Value Share, by Route of Administration, 2016 and 2025
Figure 46: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Oral, 2015–2025
Figure 47: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Injectable, 2015–2025
Figure 48: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Inhalation, 2015–2025
Figure 49: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Transdermal, 2015–2025
Figure 50: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Ocular, 2015–2025
Figure 51: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Nasal, 2015–2025
Figure 52: Global Drug Delivery Systems Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Topical, 2015–2025
Figure 53: Global Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oral, 2015–2025
Figure 54: Global Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Injectable, 2015–2025
Figure 55: Global Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Inhalation, 2015–2025
Figure 56: Global Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Transdermal, 2015–2025
Figure 57: Global Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ocular, 2015–2025
Figure 58: Global Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Nasal, 2015–2025
Figure 59: Global Gene Delivery Systems Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Topical, 2015–2025
Figure 60: Global Drug and Gene Delivery Systems Market Attractiveness, by Drug Delivery: Route of Administration, 2017–2025
Figure 61: Global Drug and Gene Delivery Systems Market Attractiveness, by Gene Delivery: Route of Administration, 2017–2025
Figure 62: Global Drug and Gene Delivery System Market Revenue (US$ Bn) Forecast, 2015–2025
Figure 63: Global Drug and Gene Delivery System Market Value Share Analysis, by Region, 2016 and 2025
Figure 64: Global Drug and Gene Delivery System Market Attractiveness, by Region, 2017–2025
Figure 65: North America Drug and Gene Delivery System Market Size (US$ Bn) and Y-o-Y Growth (%), 2015–2025
Figure 66: North America Drug Delivery System Market Attractiveness Analysis, by Country, 2017–2025
Figure 67: North America Gene Delivery System Market Attractiveness Analysis, by Country, 2017–2025
Figure 68: North America Drug Delivery System Market Value Share Analysis, by Country, 2016 and 2025
Figure 69: North America Gene Delivery System Market Value Share Analysis, by Country, 2016 and 2025
Figure 70: North America Drug and Gene Delivery System Market Value Share Analysis, by Drug Delivery System, 2016 and 2025
Figure 71: North America Drug and Gene Delivery System Market Value Share Analysis, by Gene Delivery System, 2016 and 2025
Figure 72: North America Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery, 2016 and 2025
Figure 73: North America Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery, 2016 and 2025
Figure 74: North America Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 75: North America Gene Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 76: North America Drug Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 77: North America Gene Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 78: North America Drug and Gene Delivery System Market Attractiveness Analysis, by Application, 2017–2025
Figure 79: North America Drug and Gene Delivery System Market Attractiveness Analysis, by Route of Administration, 2017–2025
Figure 80: Europe Drug and Gene Delivery System Market Size (US$ Bn) and Y-o-Y Growth (%), 2015–2025
Figure 81: Europe Drug Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 82: Europe Gene Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 83: Europe Drug Delivery System Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 84: Europe Gene Delivery System Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 85: Europe Drug and Gene Delivery System Market Value Share Analysis, by Drug Delivery System, 2016 and 2025
Figure 86: Europe Drug and Gene Delivery System Market Value Share Analysis, by Gene Delivery System, 2016 and 2025
Figure 87: Europe Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery, 2016 and 2025
Figure 88: Europe Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery, 2016 and 2025
Figure 89: Europe Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 90: Europe Gene Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 91: Europe Drug Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 92: Europe Gene Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 93: Europe Drug Delivery System Market Attractiveness Analysis, by Application, 2017–2025
Figure 94: Europe Gene Delivery System Market Attractiveness Analysis, by Route of Administration, 2017–2025
Figure 95: Asia Pacific Drug and Gene Delivery System Market Size (US$ Bn) and Y-o-Y Growth (%), 2015–2025
Figure 96: Asia Pacific Drug Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 97: Asia Pacific Gene Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 98: Asia Pacific Drug Delivery System Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 99: Asia Pacific Gene Delivery System Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 100: Asia Pacific Drug and Gene Delivery System Market Value Share Analysis, by Drug Delivery System, 2016 and 2025
Figure 101: Asia Pacific Drug and Gene Delivery System Market Value Share Analysis, by Gene Delivery System, 2016 and 2025
Figure 102: Asia Pacific Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery, 2016 and 2025
Figure 103: Asia Pacific Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery, 2016 and 2025
Figure 104: Asia Pacific Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 105: Asia Pacific Gene Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 106: Asia Pacific Drug Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 107: Asia Pacific Gene Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 108: Asia Pacific Drug Delivery System Market Attractiveness Analysis, by Application, 2017–2025
Figure 109: Asia Pacific Gene Delivery System Market Attractiveness Analysis, by Route of Administration, 2017–2025
Figure 110: Latin America Drug and Gene Delivery System Market Size (US$ Bn) and Y-o-Y Growth (%), 2015–2025
Figure 111: Latin America Drug Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 112: Latin America Gene Delivery System Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 113: Latin America Drug Delivery System Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 114: Latin America Gene Delivery System Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 115: Latin America Drug and Gene Delivery System Market Value Share Analysis, by Drug Delivery System, 2016 and 2025
Figure 116: Latin America Drug and Gene Delivery System Market Value Share Analysis, by Gene Delivery System, 2016 and 2025
Figure 117: Latin America Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery, 2016 and 2025
Figure 118: Latin America Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery, 2016 and 2025
Figure 119: Latin America Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 120: Latin America Gene Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 121: Latin America Drug Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 122: Latin America Gene Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 123: Latin America Drug and Gene Delivery System Market Attractiveness Analysis, by Application, 2017–2025
Figure 124: Latin America Drug and Gene Delivery System Market Attractiveness Analysis, by Route of Administration, 2017–2025
Figure 125: Middle East & Africa Drug and Gene Delivery System Market Size (US$ Bn) and Y-o-Y Growth (%), 2015–2025
Figure 126: Middle East & Africa Drug Delivery System Market Attractiveness Analysis, by Country/Sub-Region, 2017–2025
Figure 127: Middle East & Africa Gene Delivery System Market Attractiveness Analysis, by Country/Sub-Region, 2017–2025
Figure 128: Middle East & Africa Drug Delivery System Market Value Share Analysis, by Country/Sub-Region, 2016 and 2025
Figure 129: Middle East & Africa Gene Delivery System Market Value Share Analysis, by Country/Sub-Region, 2016 and 2025
Figure 130: Middle East & Africa Drug and Gene Delivery System Market Value Share Analysis, by Drug Delivery System, 2016 and 2025
Figure 131: Middle East & Africa Drug and Gene Delivery System Market Value Share Analysis, by Gene Delivery System, 2016 and 2025
Figure 132: Middle East & Africa Gene Delivery System Market Value Share Analysis, by Viral Gene Delivery, 2016 and 2025
Figure 133: Middle East & Africa Gene Delivery System Market Value Share Analysis, by Non-viral Gene Delivery, 2016 and 2025
Figure 134: Middle East & Africa Drug Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 135: Middle East & Africa Gene Delivery System Market Value Share Analysis, by Application, 2016 and 2025
Figure 136: Middle East & Africa Drug Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 137: Middle East & Africa Gene Delivery System Market Value Share Analysis, by Route of Administration, 2016 and 2025
Figure 138: Middle East & Africa Drug and Gene Delivery System Market Attractiveness Analysis, by Application, 2017–2025
Figure 139: Middle East & Africa Drug and Gene Delivery System Market Attractiveness Analysis, by Route of Administration, 2017–2025

 

.